Trial
NCT01499355
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Biogen
Collaborators
—
Condition
Lupus Nephritis
Intervention
BIIB023
Why stopped
Results from pre-specified criteria did not demonstrate sufficient efficacy to warrant continuation of the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-01-18